This is a study to evaluate the long-term safety and effectiveness of Invega XR, given in flexible doses, to teens with schizophrenia. This national study is currently recruiting teens ages 12 years to 17 years old who have this condition.
Read moreThe approval by the FDA for the use of Risperdal in the treatment of schizophrenia and bipolar disorder in children is a momentous event.... Read more »
In one of the biggest studies of its kind, researchers have established a way to more accurately predict the onset of psychosis in high... Read more »
At the 2008 convention, I was fortunate to catch up with Dr. Ken Duckworth, NAMI's medical director, and his colleague, Stephen... Read more »
This SharePost is the first of a two-part series and examines a greatly disabling symptom of schizophrenia: cognitive deficit. I quickly... Read more »
"I think the most important thing is to accept the disorder like any other medical disorder, that treatment works and that recovery is not... Read more »
Teen years are difficult -- for both the teens and their families. Add depression to the situation, and it can be especially difficult to know... Read more »
This is a study to determine if flexibly-dosed Geodon is a safe and effective treatment for adolescents with schizophrenia. This international study... Read more »
This is a study to evaluate the long-term safety and tolerability of flexible doses of extended-release Invega in teens who have been diagnosed with... Read more »
People who smoke the highly-potent form of cannabis called skunk are almost seven times more likely to develop a psychotic illness than those who use... Read more »
Source: Medifocus Guidebook on: Schizophrenia
Signs and Symptoms of SchizophreniaThere are three major categories of symptoms associated with schizophrenia: Positive symptoms Negative symptoms ... Read more »